P
PBYI
Puma Biotechnology Inc
7.51
+0.54+7.75%After Hours: 7.60 +0.09 +1.20%19:41 04/08 EDT
OPEN/PREV CLOSE7.17/6.97
TODAY RANGE7.11-7.54
VOL463.63K
MARKET CAP382.08M
52 WEEK RANGE2.575-7.68
AVG VOL (3M)407.96K
% TURNOVER0.91%
TURNOVER--
P/E (TTM)12.23
% RANGE5.81%
EPS(TTM)0.6142
P/E(FORWARD)30.04
P/B2.904
BVPS2.586
DIVIDEND--
P/S1.658
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP322.94M
SHARES OUTSTANDING50.88M
NEXT EARNINGS05/06-05/11
FREE FLOAT43.00M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Reuters·1d ago
Puma Biotechnology announces annual shareholder meeting
TipRanks·03/02 00:08
Puma Biotechnology Balances Growth, Trials and Profitability
Simply Wall St·02/28 02:30
Puma Biotechnology (PBYI) Margin Resilience Tests Bearish Earnings Forecasts In FY 2025 Results
Benzinga·02/27 17:05
12 Health Care Stocks Moving In Friday's Intraday Session
Seeking Alpha·02/27 02:38
Puma anticipates $194M–$198M NERLYNX revenue for 2026 while advancing alisertib clinical programs
TipRanks·02/26 22:00
Puma Biotechnology reports Q4 EPS 26c vs. 39c last year
TipRanks·02/26 21:59
Puma Biotechnology sees Q1 revenue $38M-$42M, one estimate $49M
Reuters·02/26 21:57
Puma Biotechnology Q4 product revenue rises to $59.9 mln
Seeking Alpha·02/26 21:39
Puma Biotechnology Non-GAAP EPS of $0.29 beats by $0.06, revenue of $75.5M beats by $6.9M
Same Industry
Name/Symbol
Change%
Price